Related Products

Summary Of Brigatinib-API-Small Molecules

Chemical Name

Brigatinib

CAS No.

1197953-54-0

Molecular Formula

C29H39ClN7O2P

Innovator

Developer

Indication

Anaplastic Large Cell Lymphoma; Large Cell Lymphoma; Non-Small Cell Lung Cancer

Therapeutic Area

Oncology

Market Status

Launched

Approval Year

Patent Expiry